105 related articles for article (PubMed ID: 8316463)
1. Application of radioimmunodetection with a radiolabeled monoclonal antibody to CEA (BW 431/26) in colorectal and breast cancer.
Lind P
Pathol Biol (Paris); 1993 Jan; 41(1):39. PubMed ID: 8316463
[No Abstract] [Full Text] [Related]
2. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
4. Anti-CEA labelling kit BW 431/26. Results of the European multicenter trial.
Steinsträsser A; Oberhausen E
Nuklearmedizin; 1995 Dec; 34(6):232-42. PubMed ID: 8596740
[TBL] [Abstract][Full Text] [Related]
5. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibodies].
Murayama H; Watanabe T; Sakamoto J; Tadokoro M; Takagi H; Sakuma S
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1732-41. PubMed ID: 2594001
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma.
Buchegger F; Mach JP; Pèlegrin A; Gillet M; Vogel CA; Buclin T; Ryser JE; Delaloye B; Delaloye AB
J Nucl Med; 1995 Mar; 36(3):420-9. PubMed ID: 7884504
[TBL] [Abstract][Full Text] [Related]
7. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
Goldenberg DM; Wlodkowski TJ; Sharkey RM; Silberstein EB; Serafini AN; Garty II; Van Heertum RL; Higginbotham-Ford EA; Kotler JA; Balasubramanian N
J Nucl Med; 1993 Jan; 34(1):61-70. PubMed ID: 8418273
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA 102: whole IgG versus F(ab')2 fragments].
Wada K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):266-73. PubMed ID: 1513308
[TBL] [Abstract][Full Text] [Related]
10. Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass.
Williams LE; Bares RB; Fass J; Hauptmann S; Schumpelick V; Buell U
Eur J Nucl Med; 1993 Apr; 20(4):345-7. PubMed ID: 8491228
[TBL] [Abstract][Full Text] [Related]
11. Technology evaluation: CEA-Scan, Immunomedics Inc.
Eccles SA
Curr Opin Mol Ther; 1999 Dec; 1(6):737-44. PubMed ID: 19629871
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.
Boxer G; Stuart-Smith S; Flynn A; Green A; Begent R
Br J Cancer; 1999 May; 80(5-6):922-6. PubMed ID: 10360677
[TBL] [Abstract][Full Text] [Related]
13. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
[TBL] [Abstract][Full Text] [Related]
14. Pilot, multicenter and prospective trials with an anti-CEA antibody.
Buraggi GL; Gasparini M; Seregni E; Bombardieri E; Regalia E; Maffioli L
Int J Biol Markers; 1992; 7(3):189-92. PubMed ID: 1431344
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunodetection in cancer identification.
Goldenberg DM; Larson SM
J Nucl Med; 1992 May; 33(5):803-14. PubMed ID: 1569493
[No Abstract] [Full Text] [Related]
16. Anti-CEA and other antibodies in the study of gastrointestinal tumors.
Lastoria S; Caracò C; Vergara E; Castelli L; Salvatore M
Int J Biol Markers; 1992; 7(3):198-202. PubMed ID: 1431346
[TBL] [Abstract][Full Text] [Related]
17. Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor.
Oriuchi N; Endo K; Watanabe N; Sugiyama S; Asao T; Takenoshita S; Nagamachi Y; Baum RP
J Nucl Med; 1995 Apr; 36(4):679-83. PubMed ID: 7699464
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 steps targetting with bispecific antibody.
Hamy A; Curtet C; Paineau J; Chatal JF; Visset J
Tumori; 1995; 81(3 Suppl):103-6. PubMed ID: 7571036
[TBL] [Abstract][Full Text] [Related]
19. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study].
Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH
Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155
[TBL] [Abstract][Full Text] [Related]
20. [Radioimmunoscintigraphy of colorectal tumors: state of the art (2)].
Barzen G; Felix R
Aktuelle Radiol; 1992 Sep; 2(5):262-70. PubMed ID: 1420384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
